Evidence map›Paper›PMID 34573280›Full record

ArticleGenes2021

Targeted NGS Yields Plentiful Ultra-Rare Variants in Inborn Errors of Immunity Patients.

Alice Grossi, Maurizio Miano, Marina Lanciotti, Francesca Fioredda, Daniela Guardo, Elena Palmisani, Paola Terranova, Giuseppe Santamaria, Francesco Caroli, Roberta Caorsi and 4 more

Abstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Autoimmune Neutropenia and Immune-Dysregulation in a Patient Carrying aInternational journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alice GrossiUOSD Laboratory of Genetics and Genomics of Rare Diseases, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
Maurizio MianoHematology-Oncology Stem Cell Transplantation Pole, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.ORCID 0000-0002-9816-1704
Marina LanciottiHematology-Oncology Stem Cell Transplantation Pole, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
Francesca FioreddaHematology-Oncology Stem Cell Transplantation Pole, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
Daniela GuardoHematology-Oncology Stem Cell Transplantation Pole, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
Elena PalmisaniHematology-Oncology Stem Cell Transplantation Pole, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
Paola TerranovaHematology-Oncology Stem Cell Transplantation Pole, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
Giuseppe SantamariaUOSD Laboratory of Genetics and Genomics of Rare Diseases, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
Francesco CaroliUOSD Laboratory of Genetics and Genomics of Rare Diseases, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.ORCID 0000-0003-1828-6900
Roberta CaorsiCenter for Autoinflammatory Diseases and Immune-Deficiencies, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
Stefano VolpiCenter for Autoinflammatory Diseases and Immune-Deficiencies, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.ORCID 0000-0002-7129-868X
Marco GattornoCenter for Autoinflammatory Diseases and Immune-Deficiencies, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
Carlo DufourHematology-Oncology Stem Cell Transplantation Pole, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.
Isabella CeccheriniUOSD Laboratory of Genetics and Genomics of Rare Diseases, IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy.ORCID 0000-0001-8732-1955

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inborn errors of immunity (IEI) include a large group of inherited diseases sharing either poor, dysregulated, or absent and/or acquired function in one or more components of the immune system. Next-generation sequencing (NGS) has driven a rapid increase in the recognition of such defects, though the wide heterogeneity of genetically diverse but phenotypically overlapping diseases has often prevented the molecular characterization of the most complex patients. Two hundred and seventy-two patients were submitted to three successive NGS-based gene panels composed of 58, 146, and 312 genes. Along with pathogenic and likely pathogenic causative gene variants, accounting for the corresponding disorders (37/272 patients, 13.6%), a number of either rare (probably) damaging variants in genes unrelated to patients' phenotype, variants of unknown significance (VUS) in genes consistent with their clinics, or apparently inconsistent benign, likely benign, or VUS variants were also detected. Finally, a remarkable amount of yet unreported variants of unknown significance were also found, often recurring in our dataset. The NGS approach demonstrated an expected IEI diagnostic rate. However, defining the appropriate list of genes for these panels may not be straightforward, and the application of unbiased approaches should be taken into consideration, especially when patients show atypical clinical pictures.

Indexed as

Gene FrequencyAdolescentFemaleGene-Environment InteractionGenetic TestingHigh-Throughput Nucleotide SequencingHumansImmune System DiseasesMaleMetabolism, Inborn ErrorsMutationSequence Analysis, DNAautoinflammationbone marrow failuregenotype-phenotype correlationlymphoproliferationnext-generation sequencing (NGS)NGS-based gene panels

Identifiers

PMID34573280
PMCPMC8469131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.